{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T00:18:19Z","timestamp":1715300299546},"reference-count":16,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2022,7,30]]},"DOI":"10.1536\/ihj.18-241","type":"journal-article","created":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T22:13:55Z","timestamp":1659132835000},"page":"786-792","source":"Crossref","is-referenced-by-count":0,"title":["Cardiac Dopamine-Secreting Paraganglioma with Involved Skull Base and Retroperitoneum After a History of Pheochromocytoma Post Adrenalectomy"],"prefix":"10.1536","volume":"63","author":[{"given":"Chee Eng","family":"Hoo","sequence":"first","affiliation":[{"name":"School of Medicine, National Yang-Ming University"},{"name":"Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Sung","family":"Kuo","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang-Ming University"},{"name":"Division of Endocrinology and Metabolism, Department of Medicine, Taipei Veterans General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Yang","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang-Ming University"},{"name":"Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hsun","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang-Ming University"},{"name":"Division of Cardiology, Department of Medicine, Taipei Veterans General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An-Hang","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang-Ming University"},{"name":"Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiao-Po","family":"Hsu","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang-Ming University"},{"name":"Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Martucci VL, Emaminia A, del Rivero J, et al. Succinate dehydrogenase gene mutations in cardiac paragangliomas. Am J Cardiol 2015; 115: 1753-9.","DOI":"10.1016\/j.amjcard.2015.03.020"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Eisenhofer G, Goldstein DS, Sullivan P, et al. Biochemical and clinical manifestations of dopamine-producing paragangliomas: Utility of plasma methoxytyramine. J Clin Endocrinol Metab 2005; 90: 2068-75.","DOI":"10.1210\/jc.2004-2025"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Feldman JM, Blalock JA, Zern RT, et al. Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas. Am J Clin Pathol 1979; 72: 175-85.","DOI":"10.1093\/ajcp\/72.2.175"},{"key":"4","unstructured":"4. Proye C, Fossati P, Fontaine P, et al. Dopamine-secreting pheochromocytoma: An unrecognized entity? Classification of pheochromocytomas according to their type of secretion. Surgery 1986; 100: 1154-62."},{"key":"5","unstructured":"5. Foo SH, Chan SP, Ananda V, Rajasingam V. Dopamine-secreting phaeochromocytomas and paragangliomas: Clinical features and management. Singapore Med J 2010; 51: e89-93."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen YY, Huang WC, Huang MH, Lu TM, Hsu CP. The intrapericardial paraganglioma presenting as ascites and hemopericardium with impending tamponade. Int Heart J 2018; 59: 664- 7.","DOI":"10.1536\/ihj.17-150"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Lee CC, Chua S, Huang SC, Lee FY, Chung SY. Intrapericardial paraganglioma with intratumoral coronary arterial aneurysm and an arteriovenous fistula. J Am Soc Echocardiogr 2009; 22: 211. e1-3.","DOI":"10.1016\/j.echo.2008.12.001"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Osinga TE, Links TP, Dullaart RPF, et al. Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma. FASEB J 2017; 31: 2226-40.","DOI":"10.1096\/fj.201601131R"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Favier J, Igaz P, Burnichon N, et al. Rationale for antiangiogenic therapy in pheochromocytoma and paraganglioma. Endocr Pathol 2012; 23: 34-42.","DOI":"10.1007\/s12022-011-9189-0"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Sawka AM, Jaeschke R, Singh RJ, Young WF Jr. A comparison of biochemical tests for pheochromocytoma: Measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. J Clin Endocrinol Metab 2003; 88: 553-8.","DOI":"10.1210\/jc.2002-021251"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Rao D, Peitzsch M, Prejbisz A, et al. Plasma methoxytyramine: Clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma. Eur J Endocrinol 2017; 177: 103-13.","DOI":"10.1530\/EJE-17-0077"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Lenders JW, Duh QY, Eisenhofer G, et al. Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2014; 99: 1915-42.","DOI":"10.1210\/jc.2014-1498"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Imani F, Agopian VG, Auerbach MS, et al. 18f-fdopa pet and pet\/ct accurately localize pheochromocytomas. J Nucl Med 2009; 50: 513-9.","DOI":"10.2967\/jnumed.108.058396"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kim KY, Kim JH, Hong AR, et al. Disentangling of malignancy from benign pheochromocytomas\/paragangliomas. PLoS One 2016; 11: e0168413.","DOI":"10.1371\/journal.pone.0168413"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Poirier \u00c9, Thauvette D, Hogue JC. Management of exclusively dopamine-secreting abdominal pheochromocytomas. J Am Coll Surg 2013; 216: 340-6.","DOI":"10.1016\/j.jamcollsurg.2012.10.002"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Amar L, Servais A, Gimenez-Roqueplo AP, Zinzindohoue F, Chatellier G, Plouin PF. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. J Clin Endocrinol Metab 2005; 90: 2110-6.","DOI":"10.1210\/jc.2004-1398"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/4\/63_18-241\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T05:25:35Z","timestamp":1715232335000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/63\/4\/63_18-241\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,30]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.18-241","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,30]]},"article-number":"18-241"}}